Safety and utility of atropine addition during dobutamine stress echocardiography for the assessment of viable myocardium in patients with severe left ventricular dysfunction

European Heart Journal

Volumn 19, Issue 11, 1998, Pages 1712-1718

  Poldermans, D ^a   Rambaldi, R ^a   Bax, J J ^a   Cornel, J H ^a   Thomson, I R ^a,b   Valkema, R ^a   Boersma, E ^a   Fioretti, P M ^a   Breburda, C S M ^a   Roelandt, J R T C ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^b UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Atropine addition; Dobutamine stress echocardiography; Poor left ventricular function

Indexed keywords

ATROPINE; CARDIOTONIC AGENT; DOBUTAMINE;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; DIAGNOSTIC VALUE; FEMALE; HEART ARRHYTHMIA; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE; HEART MUSCLE ISCHEMIA; HEART RATE; HUMAN; HYPOTENSION; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; SAFETY; ST SEGMENT; STRESS ECHOCARDIOGRAPHY;

ADULT; AGED; ATROPINE; CARDIOTONIC AGENTS; DOBUTAMINE; DRUG SYNERGISM; ELECTROCARDIOGRAPHY; EXERCISE TEST; FEASIBILITY STUDIES; FEMALE; HEART RATE; HEMODYNAMIC PROCESSES; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PARASYMPATHOLYTICS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0032212376     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1053/euhj.1998.1126     Document Type: Article

References (19)

1. [1] Segar DS, Brown SE, Sawada SG, Ryan T, Feigenbaum H. Dobutamine stress echocardiography: correlation with coronary lesion severity as determined by quantitative angiography. J Am Coll Cardiol 1992; 19: 1197-1202.
2. [2] Poldermans D, Boersma E, Fioretti PM, van Urk H, Boomsma F, Man in 't Veld AJ. Cardiac chronotropic responsiveness to beta-adrenoceptor is reduced in the elderly. J Am Coll Cardiol 1995; 25: 995-9.
3. [3] Ling LH, Pellikka PA, Mahoney DW et al. Atropine augmentation in dobutamine stress echocardiography: Role and incremental value in clinical practice setting. J Am Coll Cardiol 1996; 28: 551-7.
4. [4] Hepner AM, Bach DS, Armstrong WF. Early chronotropic incompetence predicts the need for atropine during dobutamine stress echocardiography. Am J Cardiol 1997; 79: 365-6.
5. [5] Pingitore A, Picano E, Quatra Colosso M et al. The atropine factor in pharmacologie stress echocardiography. J Am Coll Cardiol 1996; 27: 1164-70.
6. [6] Mertes H, Sawada SG, Ryan T et al. Symptoms, adverse effects and complications associated with dobutamine stress echocardiography: experience in 1118 patients. Circulation 1993; 88: 15-19.
7. [7] Marwick T, D'Hondt AM, Baudhuin T et al. Optimal use of dobutamine stress for the detection and evaluation of coronary artery disease: Combination with echocardiography or scintygraphy, or both? J Am Coll Cardiol 1993; 22: 159-67.
8. [8] Poldermans D, Fioretti PM, Boersma E et al. Safety of dobutamine-atropine stress echocardiography in patients with suspected or proven coronary artery disease. Am J Cardiol 1994; 73: 456-9.
9. [9] Picano E, Mathias W, Pingitore A, Bigi R, Previtali M. Safety and tolerability of dobutamine-atropine stress echocardiography: a prospective, multicentre study. Lancet 1994; 344: 1190-2.
10. [10] Anthopoulos LP, Bonou MS, Kardaras FG et al. Stress echocardiography in elderly patients with coronary artery disease. J Am Coll Cardiol 1996; 28: 52-9.
11. [11] Panza JA, Curiel RV, Laurienzo JM, Quyyumi AA, Dilsizian V. Relation between ischemic threshold measured during DASE and known indices of poor prognosis in patients with coronary artery disease. Circulation 1995; 92: 2095-2101.
12. [12] Cigarroa CG, deFilippi CR, Brickner E, Alvarez LG, Wait MA, Grayburn PA. Dobutamine stress echocardiography identifies hibernating myocardium and predicts recovery of left ventricular function after coronary revascularization. Circulation 1993; 88: 430-6.
13. [13] Cornel JH, Balk AHMM, Boersma E et al. Safety and feasibility of dobutamine-atropine stress echocardiography in patients with ischemic left ventricular dysfunction. J Am Soc Echocardiogr 1996; 9: 27-32.
14. [14] Afridi I, Kleinman NS, Raizner AE, Zoghbi WA. Dobutamine echocardiography in myocardial hibernation. Optimal dose and accuracy in predicting recovery of ventricular function after coronary angioplasty. Circulation 1995; 91: 663-670.
15. [15] Rahimtoola SH. Hibernating myocardium has reduced blood flow at rest that increases with low-dose dobutamine. Circulation 1996; 94: 3055-61.
16. [16] Nagueh SF, Zoghbi WA. Stress echocardiography for the assessment of myocardial ischemia and viability. Curr Probl Cardiol 1996; 21: 445-520.
17. [17] Bourdillon PDV, Broderick TM, Sawada SG et al. Regional wall motion index for infarct and noninfarct regions after reperfusion in acute myocardial infarction: comparison with global wall motion index. J Am Soc Echocardiogr 1989; 2: 398-407.
18. [18] Salustri A, Fioretti PM, Pozzoli MMA, McNeill AJ, Roelandt JRTC. Dobutamine stress echocardiography: its role in the diagnosis of coronary artery disease. Eur Heart J 1992; 13: 70-77.
19. [19] Williams MJ, Odabashian J, Lauer MS, Thomas JD, Marwick TH. Prognostic value of dobutamine echocardiography in patients with left ventricular dysfunction. J Am Coll Cardiol 1996; 27: 132-9.